NCT03687372

Study of A-101 Topical Solution for the Treatment of Common Warts

A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 503 (actual)
• Sponsor: Aclaris Therapeutics, Inc. · Industry
• Sex: All
• Age: 2 Years
• Healthy volunteers: Not accepted

Summary

A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

Detailed description

A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts

Conditions

• Common Wart

Interventions

Type	Name	Description
DRUG	A-101	hydrogen peroxide topical solution 45%
OTHER	vehicle	vehicle as a topical solution

Timeline

• Start date: 2018-09-17
• Primary completion: 2019-06-20
• Completion: 2019-09-06
• First posted: 2018-09-27
• Last updated: 2020-10-05
• Results posted: 2020-10-05

Locations

24 sites across 1 country: United States

Regulatory

• FDA-regulated drug study